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This study evaluated the antibacterial activity of propolis-based toothpastes used as intracanal medication 
in endodontic treatment. The propolis-based toothpastes were prepared using an extract established in 
previous studies (identified as A70D and D70D). Calcium hydroxide paste was used as a control. The 
bacteria employed were Streptococcus mutans (ATCC 25175), Staphylococcus aureus (ATCC 6538), 
Staphylococcus aureus (ATCC 25923), Kocuria rhizophila (ATCC 9341), Escherichia coli (ATCC 
10538), Pseudomonas aeruginosa (ATCC 27853), Enterococcus hirae (ATCC 10541), Streptococcus 
mutans (ATCC 25175). Five field strains isolated from saliva were used: Staphylococcus spp. (23.1 
- coagulase positive), Staphylococcus spp. (23.5 - coagulase negative), Staphylococcus spp. (26.1 - 
coagulase positive), Staphylococcus spp. (26.5 - coagulase negative) and Staphylococcus epidermidis 
(6epi). The diffusion-well method on double-layer agar was used in a culture medium of Tryptic Soy 
Agar. The plates were kept at room temperature for two hours to allow the diffusion of pastes in the 
culture medium, and then incubated at 35º C for twenty-four hours in aerobiosis and in microaerophilia 
(S. mutans). After this period, the total diameter of the inhibition halo was measured. The results were 
analyzed by ANOVA analysis of variance, followed by the Tukey test at p<0.05. The propolis-based 
toothpastes presented antibacterial activity against 83.3% of the analyzed bacteria. For 66.7% of these 
bacteria, the propolis-based toothpastes exhibited greater antibacterial activity than calcium hydroxide. 
The present results allow us to conclude that the experimental pastes A70D and D70D showed good 
activity against aerobic bacteria, proving more effective than calcium hydroxide.
Uniterms: Propolis/antibacterial activity. Tooth paste/with propolis/antibacterial activity. Endodontics/
treatment.
O objetivo deste estudo foi avaliar a atividade antibacteriana de formas farmacêuticas a base de própolis 
para uso no tratamento endodôntico como medicação intracanal. As formulações de própolis, em forma 
de pastas, foram preparadas a partir de um extrato pré-estabelecido em estudos anteriores e identificadas 
como A70D e D70D. Como controle, foi utilizado pasta de hidróxido de cálcio. As bactérias utilizadas 
foram: Streptococcus mutans (ATCC 25175), Staphylococcus aureus (ATCC 6538), Staphylococcus 
aureus (ATCC 25923), Kocuria rhizophila (ATCC 9341), Escherichia coli (ATCC 10538), Pseudomonas 
aeruginosa (ATCC 27853), Enterococcus hirae (ATCC 10541), Streptococcus mutans (ATCC 25175) 
e 5 cepas de campo isoladas da saliva: Staphylococcus spp. (23.1 - coagulase positiva), Staphylococcus 
spp. (23.5 - coagulase negativa), Staphylococcus spp. (26.1 - coagulase positiva), Staphylococcus spp. 
(26.5 - coagulase negativa) e Staphylococcus epidermidis (6epi). Foi utilizado o método poço difusão 
em camada dupla de ágar, em meio de cultura Tryptic Soy Agar. As placas foram mantidas à temperatura 
ambiente por 2 h para permitir a difusão das pastas no meio de cultura, e então incubadas a 35 ºC por 24 h 
em aerobiose e em microaerofilia (S. mutans). Após este período, foi medido o diâmetro total do halo 
de inibição. Os resultados foram submetidos ao teste de análise de variância ANOVA seguido do teste 
de Tukey com p<0,05. As pastas a base de própolis apresentaram atividade antibacteriana contra 83,3% 
das bactérias analisadas. Para 66,7% das bactérias, as pastas de própolis apresentaram maior atividade 
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antibacteriana que o hidróxido de cálcio, e este foi mais efetivo apenas para Streptococcus mutans (ATCC 
25175), Staphylococcus aureus (ATCC 25923) e Pseudomonas aeruginosa (ATCC 27853). De acordo 
com a metodologia utilizada, pode-se concluir que as pastas experimentais A70D e D70D apresentam 
boa atividade contra bactérias aeróbias, sendo superior ao hidróxido de cálcio. 
Unitermos: Própolis/atvidade antibacteriana. Pasta de dente/com própolis/atividade antibacteriana. 
Endodontia/tratamento.
INTRODUCTION
Intracanal medication helps in the fight against root 
canal system infection, and can also stimulate the repair 
process of apical tissues. To achieve this, it must eliminate 
the bacteria and fungi surviving in biomechanical prepara-
tion, act as a physicochemical barrier against reinfection 
by mouth microorganisms, and decrease peri-radicular 
inflammation.
Propolis, a substance produced by bees for protec-
tion of the hive against microorganisms (Trevisan, 1983), 
has been widely used in popular medicine. In the scientific 
community, propolis has demonstrated antibacterial (Wu-
yuan, Green, Birch , 1990; Grange, Davey, 1990; Santos 
et al., 2002; Koru et al., 2007), antifungal (Kujumgiev et 
al., 1999; Quintero-Mora et al., 2008), anti-inflammatory 
(Dobrowolski et al., 1991; Hu et al., 2005; Sosa, 2007), 
cicatrizant (Perri de Carvalho, Tagliavini, Tagliavini, 
1991) and immunomodulator (Dimov et al., 1992; Simões 
et al., 2004) action.
Few studies have associated propolis and its anti-
inflammatory and antibacterial effects with endodontic 
treatment, such as those by Heys (1980), Matos (1989) 
and Sabir et al. (2005). Perhaps this is due to the intrinsic 
difficulty of introducing propolis and removing it from the 
internal side of the root canal.
Therefore, the purpose of this study was to evaluate 
the antibacterial activity of propolis-based pharmaceu-
tical forms for use in endodontic treatment as intracanal 
medication.
MATERIAL AND METHODS
The propolis-based formulas were prepared from a 
brown extract (called PPE1) predefined in previous stu-
dies (Victorino et al., 2007), which was collected in the 
Northeastern state of Paraná, Brazil. The solvent used in 
the formulas was an ethylic alcohol based solution. The 
formulas, in the form of toothpastes, were labeled A70D 
and D70D. P.A. calcium hydroxide prepared with propy-
lene glycol was used as a control formula.
Twelve bacteria were used in the study [eleven aero-
bic and one facultative anaerobic - Streptococcus mutans 
(ATCC 25175)], seven of which were standard strains: 
Staphylococcus aureus (ATCC 6538), Staphylococcus 
aureus (ATCC 25923), Kocuria rhizophila (ATCC 9341), 
Escherichia coli (ATCC 10538), Pseudomonas aerugino-
sa (ATCC 27853), Enterococcus hirae (ATCC 10541) and 
Streptococcus mutans (ATCC 25175) and five, community 
field strains isolated from saliva: Staphylococcus spp. 
(23.1 - coagulase positive), Staphylococcus spp. (23.5 - co-
agulase negative), Staphylococcus spp. (26.1 - coagulase 
positive), Staphylococcus spp. (26.5 - coagulase negative) 
and Staphylococcus epidermidis (6epi).
The technique employed to evaluate the toothpastes’ 
antibacterial activity was that of diffusion on double-layer 
Agar, described by Grove, Randall (1955), which was 
performed in quadruplicate. The culture medium Tryptic 
Soy Agar (Difco™, USA) was distributed in petri dishes 
(20x100mm) sterilized to form a base-layer of 12.0 mL. 
After medium solidification, 8.0ml of Tryptic Soy Agar 
containing 1% of bacterial inoculation (at half-scale con-
centration proposed by McFarland), were spread over the 
base-layer to form a seed layer (seeding). Subsequently, 
six 5.0mm-wide wells were made in each Petri dish. The 
A70D, D70D and calcium hydroxide toothpastes were 
placed within the wells using sterilized metallic spatulas. 
The dishes were pre-incubated at room temperature 
(25 ºC) for two hours to allow diffusion of the toothpastes 
by the culture medium, and then incubated at 35 ºC for 
twenty-four hours in aerobiosis (S. aureus, Staphylococcus 
spp., K. rhizophila, E .coli, P. aeruginosa, E. hirae), or in 
microaerophilia using the candle jar method (S. mutans). 
After this period, the total inhibition zone diameter was 
measured with a millimeter ruler, without deducting 
the diameter of the well. The results were submitted to 
ANOVA analysis of variance, followed by the Tukey test 
at p<0.05. 
RESULTS
The inhibition zone of test and calcium hydroxide 
toothpastes, as well as the arithmetic mean of respective 
antibacterial activities (in quadruple), are expressed in 
Figure 1 and Table I, respectively. The propolis-based 
toothpastes demonstrated antibacterial activity in ten out 
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of twelve analyzed bacteria (83.3%), with the exception of 
P. aeruginosa (ATCC 27853) and E. hirae (ATCC 10541), 
which showed resistance even to calcium hydroxide.
For the calcium hydroxide paste, the mean inhibition 
zone ranged from zero to 25.5 mm, while the propolis-
based toothpastes this ranged from zero to 28.0 mm. For 
eight out of the twelve bacteria (66.7%), the propolis-
based toothpastes presented higher antibacterial activity 
than calcium hydroxide, while the latter was more effec-
tive against S. mutans (ATCC 25175), S. aureus (ATCC 
25923) and P. aeruginosa (ATCC 27853). The improved 
results found for propolis-based toothpastes over calcium 
hydroxide were statistically significant, according to 
ANOVA, followed by Tukey test (p<0.05). 
DISCUSSION
This study is part of a line of research line pursuing 
the development of intracanal medication, in which pro-
polis is the main component. Perhaps, this study may 
serve to explain why previous microbiologic studies have 
employed propolis in its raw form, or as an extract. Since 
this extract presents a resinous quality, it does not represent 
a good option because the medication must be introduced 
directly into root canals, making its removal extremely 
difficult. The development of a paste formula with aqueous 
components, containing the minimal quantity of propolis 
extract to maintain its biological activities, would render 
this therapeutic option viable.
Among the substances employed as intracanal 
medication, calcium hydroxide has been the most widely 
used and recommended given its biological properties and 
antimicrobial action (Sathorn, Parashos, Messer, 2007.). 
Its high pH (around 12.5, resulting from the release of 
hydroxyl ions) exerts a deleterious effect over the bac-
terial cells as it damages their respective cellular mem-
branes (Freeman, Crapo, 1982), denatures their proteins 
(Siqueira, Uzeda, 1997), and alters their DNA (Imlay, 
Linn, 1988).
TABLE I - Susceptibility test of pathogenic microorganisms to propolis-based toothpastes for use in endodontics. Mean inhibition 
zone (mm)*
A70D D70D Ca(OH)
2
Staphylococcus aureus (ATCC 6538) 19.8 19.8 16.3
Staphylococcus aureus (ATCC 25923) 20.3 20.8 25.5
Staphylococcus spp. (23.1 - coagulase positive)** 20.5 20.5 14.8
Staphylococcus spp. (23.5 - coagulase negative)** 25.8 24.5 20.3
Staphylococcus spp. (26.1 - coagulase positive)** 17.3 16.8 12.0
Staphylococcus spp. (26.5 - coagulase negative)** 20.5 20.5 16.8
Staphylococcus epidermidis (6epi)** 20.0 20.0 13.5
Kocuria rhizophila (ATCC 9341) 28.8 28.0 22.8
Escherichia coli (ATCC 10538) 13.0 13.0 11.5
Streptococcus mutans (ATCC 25175) 6.3 7.0 20.8
Pseudomonas aeruginosa (ATCC 27853) 0 0 11.8
Enterococcus hirae (ATCC 10541) 0 0 0
* tests in quadruple. **community field strain (saliva)
FIGURE 1 - Inhibition zones for S. epidermidis. 1: Paste A70D, 
2: Ca(OH)
2
, 3: Paste D70D, 4: Paste A70D, 5: Ca(OH)
2
, 
6: Paste D70D.
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The antimicrobial property of propolis has been 
attributed mainly to flavonoids (Greenaway, Scaysbrook, 
Whatley, 1990; Viuda-Martos et al. 2008). However, 
Kujumgiev et al. (1999) have shown that propolis antimi-
crobial activity results from the synergy between its own 
components. In this study, the authors have analyzed both 
the chemical composition and antimicrobial activity from 
extracts collected in different world regions, including tro-
pical as well as temperate areas. All of these extracts have 
demonstrated antimicrobial activity, albeit with different 
chemical characteristics. This result has also been obser-
ved by Miorin et al. (2003), who analyzed chemical and 
microbiological extracts from different regions of Brazil.
Many studies have examined propolis antimicrobial 
activity using serial dilution tests (Sonmez et al., 2005; 
Victorino et al., 2007) and diffusion tests on agar (Kujum-
giev et al., 1999; Somnes et al,. 2005; Bruschi et al. 2006).
Studies of European propolis employing diffusion test 
on agar have found diverse results. Metzner et al. (1979) 
found no diffusion zones, probably due to low diffusion of 
propolis components through agar. Brumfitt et al. (1990) 
achieved inhibition zones of 13.0mm for S. aureus and S. 
epidermidis, but no activity against Streptococcus spp. Do-
browolsky et al. (1991) however, observed inhibition zones 
of 16.0 mm for both S. aureus and for Streptococcus pyo-
genes. Boyanova et al. 2006 used the same methodology to 
evaluate antimicrobial activity of Bulgarian propolis against 
anaerobic Gram-positive and Gram-negative bacteria, and 
recorded inhibition zones greater than or equal to 15 mm for 
the majority of Gram-positive bacteria, at concentrations of 
30 µL of propolis per well.
In the present study, growth inhibition zones were 
observed for the majority of analyzed bacteria, demons-
trating that both propolis-based toothpaste and calcium 
hydroxide toothpaste were able to diffuse and exert their 
antibacterial activity in the culture medium. 
The experimental toothpastes presented similar re-
sults, and failed to present activity against P. aeruginosa 
and E. hirae. Against the different strains of S. aureus, the 
mean inhibition zone ranged from 16.8 to 25.8 mm, a mean 
similar or higher than those found by the cited authors. The 
weak activity against strains of Streptococcus mutans also 
confirms data found in the literature (Brumfitt et al., 1990; 
Bruschi et al., 2006; Duarte et al., 2006).
Compared to calcium hydroxide, the propolis-based 
toothpastes showed slightly better results; the latter having 
inhibited the growth of P. aeruginosa, while performing 
significantly better against S. mutans.
It is important to take into account that, not only 
have standard strains been utilized, but also field strains 
of Staphylococcus spp. from patients’ saliva, which dental 
professionals routinely encounter in the clinic.
Although the endodontic microbiota is mixed and 
contains largely anaerobic bacteria, the presence of resi-
dual aerobic bacteria within the root canal system, after 
seventy-two and ninety-six hours after the chemomechani-
cal preparation, was demonstrated by Leonardo (1965) and 
Assed et al. (1996). However, since this was a preliminary 
study, we used aerobic bacteria and a single facultative 
anaerobic bacterium (S. mutans). Thus, the possible lack 
of effect in this group of bacteria may be an exclusion or 
change factor for the formulas. 
CONCLUSION
The results obtained using this methodology al-
low us to conclude that the experimental propolis-based 
toothpastes showed good antibacterial activity against 
the analyzed bacteria, proving more effective than cal-
cium hydroxide-based toothpaste. However, subsequent 
studies should be conducted to examine different specific 
anaerobic bacteria that are commonly present in cases of 
endodontic infections.
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